mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.03 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.04 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |